Merck and Eisai said on Friday a combination of their cancer therapies failed to extend the lives of patients with a type of ...

Johnson & Johnson beat Wall Street’s fourth-quarter expectations as strong cancer drug sales compensated for a decline in ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

Atara Biotherapeutics said on Tuesday the U.S. health regulator had placed a clinical hold on its trials for cancer cell ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...

A team of researchers from NUS has developed a novel method to enhance the precision of cancer treatment using gold ...

A commonly-used heart drug derived from the foxglove plant can “dissolve” clusters of breast cancer cells to prevent the ...

The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...

FDA officials have telegraphed the decision for months. While the agency has long said that it did not think evidence of Red ...

Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment ...

More testing is needed, but if the same results are seen in humans, it could transform treatment of the disease.